Bladder cancer urine test shows promise for new application
This article was originally published in Clinica
Executive Summary
An Austrian team has discovered a potential new application for DiagnoCure's urine test for diagnosing recurrent bladder cancer. ImmunoCyt, an immunocytochemistry assay that detects tumour cells exfoliated in the urine of patients previously diagnosed with bladder cancer, may also hold promise for detecting upper urinary tract cancer, says lead researcher Michael Marberger, of the University of Vienna.